A citation-based method for searching scientific literature

Wissam Zam, Lina Ali. Curr Rev Clin Exp Pharmacol 2022
Times Cited: 10







List of co-cited articles
10 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Mechanisms underlying low-clinical responses to PD-1/PD-L1 blocking antibodies in immunotherapy of cancer: a key role of exosomal PD-L1.
Zi Yin, Min Yu, Tingting Ma, Chuanzhao Zhang, Shanzhou Huang, Mohammad Reza Karimzadeh, Amir Abaas Momtazi-Borojeni, Sheng Chen. J Immunother Cancer 2021
33
20

A snapshot of the PD-1/PD-L1 pathway.
Chinmoy Ghosh, Gary Luong, Yue Sun. J Cancer 2021
16
20

Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion.
Robert D Schreiber, Lloyd J Old, Mark J Smyth. Science 2011
20

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.
Freddie Bray, Jacques Ferlay, Isabelle Soerjomataram, Rebecca L Siegel, Lindsey A Torre, Ahmedin Jemal. CA Cancer J Clin 2018
20

Mechanism of action of PD-1 receptor/ligand targeted cancer immunotherapy.
Jannie Borst, Julia Busselaar, Douwe M T Bosma, Ferry Ossendorp. Eur J Immunol 2021
8
25

PD-1 and PD-L1 Checkpoint Signaling Inhibition for Cancer Immunotherapy: Mechanism, Combinations, and Clinical Outcome.
Hashem O Alsaab, Samaresh Sau, Rami Alzhrani, Katyayani Tatiparti, Ketki Bhise, Sushil K Kashaw, Arun K Iyer. Front Pharmacol 2017
770
20

The diverse functions of the PD1 inhibitory pathway.
Arlene H Sharpe, Kristen E Pauken. Nat Rev Immunol 2018
682
20

Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.
Hyuna Sung, Jacques Ferlay, Rebecca L Siegel, Mathieu Laversanne, Isabelle Soerjomataram, Ahmedin Jemal, Freddie Bray. CA Cancer J Clin 2021
20

Elevated serum soluble CD40 ligand in cancer patients may play an immunosuppressive role.
Jianping Huang, Caroline Jochems, Tara Talaie, Austin Anderson, Alessandra Jales, Kwong Y Tsang, Ravi A Madan, James L Gulley, Jeffrey Schlom. Blood 2012
82
20

Classifying Cancers Based on T-cell Infiltration and PD-L1.
Michele W L Teng, Shin Foong Ngiow, Antoni Ribas, Mark J Smyth. Cancer Res 2015
882
20

[Effect of soluble PD-L1 released by lung cancer cells in regulating the function of T lymphocytes].
Min-hua Shi, Yu-fei Xing, Zeng-li Zhang, Jian-an Huang, Yong-jing Chen. Zhonghua Zhong Liu Za Zhi 2013
19
10

Serum levels of soluble programmed death-ligand 1 (sPD-L1): A possible biomarker in predicting post-treatment outcomes in patients with early hepatocellular carcinoma.
Tudor Mocan, Maria Ilies, Iuliana Nenu, Rares Craciun, Adelina Horhat, Ruxandra Susa, Iulia Minciuna, Ioana Rusu, Lavinia-Patricia Mocan, Andrada Seicean,[...]. Int Immunopharmacol 2021
6
16

Soluble PD-1 aggravates progression of collagen-induced arthritis through Th1 and Th17 pathways.
Cuiping Liu, Juean Jiang, Li Gao, Xiaoting Wang, Xiaohan Hu, Min Wu, Jian Wu, Ting Xu, Qin Shi, Xueguang Zhang. Arthritis Res Ther 2015
68
10

Is There a Place for PD-1-PD-L Blockade in Acute Myeloid Leukemia?
Laura Jimbu, Oana Mesaros, Cristian Popescu, Alexandra Neaga, Iulia Berceanu, Delia Dima, Mihaela Gaman, Mihnea Zdrenghea. Pharmaceuticals (Basel) 2021
7
14

PD-L1 degradation pathway and immunotherapy for cancer.
Qian Gou, Chen Dong, Huihui Xu, Bibimaryam Khan, Jianhua Jin, Qian Liu, Juanjuan Shi, Yongzhong Hou. Cell Death Dis 2020
38
10


Membrane PD-L1 expression and soluble PD-L1 plasma levels in idiopathic pulmonary fibrosis-a pilot study.
Dragana Jovanovic, Marina Roksandic Milenkovic, Jelena Kotur Stevuljevic, Jelena Markovic, Vesna Ceriman, Milica Kontic, Vesna Skodric Trifunovic. J Thorac Dis 2018
23
10

Regulation of programmed-death ligand in the human head and neck squamous cell carcinoma microenvironment is mediated through matrix metalloproteinase-mediated proteolytic cleavage.
Mayuko Hira-Miyazawa, Hiroyuki Nakamura, Mariko Hirai, Yutaka Kobayashi, Hiroko Kitahara, George Bou-Gharios, Shuichi Kawashiri. Int J Oncol 2018
18
10

HIV-1 Tat protein induces PD-L1 (B7-H1) expression on dendritic cells through tumor necrosis factor alpha- and toll-like receptor 4-mediated mechanisms.
Rémi Planès, Lbachir BenMohamed, Kaoutar Leghmari, Pierre Delobel, Jacques Izopet, Elmostafa Bahraoui. J Virol 2014
40
10

Modulation of Vaccine-Induced HIV-1-Specific Immune Responses by Co-Electroporation of PD-L1 Encoding DNA.
Pierre Tannig, Antonia Sophia Peter, Dennis Lapuente, Stephan Klessing, Dominik Damm, Matthias Tenbusch, Klaus Überla, Vladimir Temchura. Vaccines (Basel) 2020
7
14

Serum soluble PD-1 plays a role in predicting infection complications in patients with acute pancreatitis.
Xingxing Yu, Yu Pan, Qinglin Fei, Xianchao Lin, Zhijiang Chen, Heguang Huang. Immun Inflamm Dis 2021
5
20

The prognostic role of soluble transforming growth factor-β and its correlation with soluble programmed death-ligand 1 in biliary tract cancer.
Jin Won Kim, Kyung-Hun Lee, Ji-Won Kim, Koung Jin Suh, Ah-Rong Nam, Ju-Hee Bang, Mei Hua Jin, Kyoung-Seok Oh, Jae-Min Kim, Tae-Yong Kim,[...]. Liver Int 2021
3
33

Soluble PD-L1 as a Predictor of the Response to EGFR-TKIs in Non-small Cell Lung Cancer Patients With EGFR Mutations.
Yijun Jia, Xuefei Li, Chao Zhao, Shengxiang Ren, Chunxia Su, Guanghui Gao, Wei Li, Fei Zhou, Jiayu Li, Caicun Zhou. Front Oncol 2020
6
16

A dimeric structure of PD-L1: functional units or evolutionary relics?
Yong Chen, Peipei Liu, Feng Gao, Hao Cheng, Jianxun Qi, George F Gao. Protein Cell 2010
50
10

Mesenchymal stem cells as living anti-inflammatory therapy for COVID-19 related acute respiratory distress syndrome.
Feng Lin, Thomas E Ichim, Sandeep Pingle, Lawrence D Jones, Santosh Kesari, Shashaanka Ashili. World J Stem Cells 2020
16
10

Soluble programmed cell death protein 1 (sPD-1) and the soluble programmed cell death ligands 1 and 2 (sPD-L1 and sPD-L2) in lymphoid malignancies.
Julie B Mortensen, Ida Monrad, Marie B Enemark, Maja Ludvigsen, Peter Kamper, Mette Bjerre, Francesco d'Amore. Eur J Haematol 2021
2
50


Secreted PD-L1 variants mediate resistance to PD-L1 blockade therapy in non-small cell lung cancer.
Bo Gong, Kazuma Kiyotani, Seiji Sakata, Seiji Nagano, Shun Kumehara, Satoko Baba, Benjamin Besse, Noriko Yanagitani, Luc Friboulet, Makoto Nishio,[...]. J Exp Med 2019
104
10

Therapeutic plasma exchange clears circulating soluble PD-L1 and PD-L1-positive extracellular vesicles.
Jacob J Orme, Elizabeth Ann L Enninga, Fabrice Lucien-Matteoni, Heather Dale, Edwin Burgstaler, Susan M Harrington, Matthew K Ball, Aaron S Mansfield, Sean S Park, Mathew S Block,[...]. J Immunother Cancer 2020
13
10

Soluble PD-L1 generated by endogenous retroelement exaptation is a receptor antagonist.
Kevin W Ng, Jan Attig, George R Young, Eleonora Ottina, Spyros I Papamichos, Ioannis Kotsianidis, George Kassiotis. Elife 2019
25
10

Plasma levels of soluble programmed death ligand 1 (sPD-L1) in WHO II/III nasopharyngeal carcinoma (NPC): A preliminary study.
Jia Yang, Man Hu, Xinbin Bai, Xingchen Ding, Li Xie, Ji Ma, Bingjie Fan, Jinming Yu. Medicine (Baltimore) 2019
8
12




Soluble PD-L1 as a Biomarker in Malignant Melanoma Treated with Checkpoint Blockade.
Jun Zhou, Kathleen M Mahoney, Anita Giobbie-Hurder, Fengmin Zhao, Sandra Lee, Xiaoyun Liao, Scott Rodig, Jingjing Li, Xinqi Wu, Lisa H Butterfield,[...]. Cancer Immunol Res 2017
194
10


Regulation of sister chromatid cohesion by nuclear PD-L1.
Jia Yu, Bo Qin, Ann M Moyer, Somaira Nowsheen, Xinyi Tu, Haidong Dong, Judy C Boughey, Matthew P Goetz, Richard Weinshilboum, Zhenkun Lou,[...]. Cell Res 2020
28
10


Increased soluble programmed death-1 (sPD-1) is associated with disease activity and radiographic progression in early rheumatoid arthritis.
S R Greisen, T K Rasmussen, K Stengaard-Pedersen, M L Hetland, K Hørslev-Petersen, M Hvid, B Deleuran. Scand J Rheumatol 2014
62
10

Clinical significance of soluble forms of immune checkpoint molecules in advanced esophageal cancer.
Juichiro Yoshida, Takeshi Ishikawa, Toshifumi Doi, Takayuki Ota, Tomoyo Yasuda, Tetsuya Okayama, Naoyuki Sakamoto, Ken Inoue, Osamu Dohi, Naohisa Yoshida,[...]. Med Oncol 2019
14
10

Soluble forms of PD-L1 and PD-1 as prognostic and predictive markers of sunitinib efficacy in patients with metastatic clear cell renal cell carcinoma.
Christopher Montemagno, Anais Hagege, Delphine Borchiellini, Brice Thamphya, Olivia Rastoin, Damien Ambrosetti, Juan Iovanna, Nathalie Rioux-Leclercq, Camillio Porta, Sylvie Negrier,[...]. Oncoimmunology 2020
12
10

Exosomal PD-L1 contributes to immunosuppression and is associated with anti-PD-1 response.
Gang Chen, Alexander C Huang, Wei Zhang, Gao Zhang, Min Wu, Wei Xu, Zili Yu, Jiegang Yang, Beike Wang, Honghong Sun,[...]. Nature 2018
10

A secreted PD-L1 splice variant that covalently dimerizes and mediates immunosuppression.
Kathleen M Mahoney, Sachet A Shukla, Nikolaos Patsoukis, Apoorvi Chaudhri, Edward P Browne, Arnon Arazi, Thomas M Eisenhaure, William F Pendergraft, Ping Hua, Hung C Pham,[...]. Cancer Immunol Immunother 2019
55
10

Smoking Is Associated With Low Levels of Soluble PD-L1 in Rheumatoid Arthritis.
Caroline Wasén, Malin C Erlandsson, Apostolos Bossios, Linda Ekerljung, Carina Malmhäll, Sofia Töyrä Silfverswärd, Rille Pullerits, Bo Lundbäck, Maria I Bokarewa. Front Immunol 2018
10
10

Prognostic significance of soluble forms of immune checkpoint PD-1/PDL1 receptor and ligand in blood plasma of gastric cancer patients.
Nikolay Evgenievich Kushlinskii, E S Gershtein, V L Chang, E A Korotkova, A A Alferov, M M Kontorshchikov, N Yu Sokolov, E I Karamysheva, N A Ognerubov, I S Stilidi. Klin Lab Diagn 2021
3
33

Age-dependent hypoxia-induced PD-L1 upregulation in patients with obstructive sleep apnoea.
Carolina Cubillos-Zapata, Cristina Balbás-García, Jose Avendaño-Ortiz, Victor Toledano, Marta Torres, Isaac Almendros, Raquel Casitas, Ester Zamarrón, Aldara García-Sánchez, Jaime Feliu,[...]. Respirology 2019
18
10

sPD-L1 Expression is Associated with Immunosuppression and Infectious Complications in Patients with Acute Pancreatitis.
Y Chen, M Li, J Liu, T Pan, T Zhou, Z Liu, R Tan, X Wang, L Tian, E Chen,[...]. Scand J Immunol 2017
23
10

PD-1 blockade improves Kupffer cell bacterial clearance in acute liver injury.
Evangelos Triantafyllou, Cathrin Lc Gudd, Marie-Anne Mawhin, Hannah C Husbyn, Francesca M Trovato, Matthew K Siggins, Thomas O'Connor, Hiromi Kudo, Sujit K Mukherjee, Julia A Wendon,[...]. J Clin Invest 2021
18
10

Pre-treatment serum levels of soluble programmed cell death-ligand 1 predict prognosis in patients with hepatitis B-related hepatocellular carcinoma.
Xue Han, Yang-Kui Gu, Shao-Long Li, Hao Chen, Min-Shan Chen, Qing-Qing Cai, Han-Xia Deng, Meng-Xuan Zuo, Jin-Hua Huang. J Cancer Res Clin Oncol 2019
27
10

Increase of Soluble Programmed Cell Death Ligand 1 in Patients with Chronic Hepatitis C.
Satoshi Yamagiwa, Toru Ishikawa, Nobuo Waguri, Soichi Sugitani, Kenya Kamimura, Atsunori Tsuchiya, Masaaki Takamura, Hirokazu Kawai, Shuji Terai. Int J Med Sci 2017
15
10


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.